Peramivir + Oseltamivir
Phase 3Completed 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Influenza
Conditions
Influenza
Trial Timeline
Mar 11, 2015 → May 14, 2020
NCT ID
NCT02369159About Peramivir + Oseltamivir
Peramivir + Oseltamivir is a phase 3 stage product being developed by BioCryst Pharmaceuticals for Influenza. The current trial status is completed. This product is registered under clinical trial identifier NCT02369159. Target conditions include Influenza.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02369159 | Phase 3 | Completed |
Competing Products
20 competing products in Influenza